Skip to main content
GameRevenueData

Developer

Miziziziz Games: Revenue & Sales Estimates

Revenue estimates for the 10 Steam games developed by Miziziziz, ranked by estimated net revenue. Available estimated lifetime net (USD): $1.1M.

Catalog Est. Lifetime Net (USD)

$1.1M

Estimates for 9 of 10 tracked games

Tracked games

10

Top Earner

Endoparasitic

$493.7K

Coverage: 10 tracked titles; 9 with net estimates; 1 without. 5 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.

Role: Developer. These are lifetime estimates for games credited to Miziziziz; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.

Recorded release dates: 2016-07-12–2026-01-31 (may include announced dates).

Largest title accounts for 45.3% of available estimated net revenue. Coverage gaps can change this share.

Showing 1–10 of the top 10 displayed entries, from 10 tracked titles. Figures include only available estimates. Search the full catalog .

Rows 1–10 · Page 1 of 1

# Game Est. lifetime net (USD) Positive reviews (raw) Release
1 Endoparasitic $493.7K 94%Positive (2.9K) Oct 24, 2022
2 Wrought Flesh $342.7K 74%Positive (805) Dec 10, 2021
3 Endoparasitic 2 $155.5K 87%Positive (609) Oct 1, 2024
4 Voyager-19 $63.2K 89%Positive (931) May 19, 2024
5 Endoparasitic VR $13.6K 88%Positive (32) Oct 31, 2023
6 Theyest Thou $12.2K 94%Positive (95) Feb 26, 2020
7 Camelot 10000CE $6.4K 91%Positive (33) Jan 31, 2026
8 InterSection $1.5K 70%Positive (10) Jul 12, 2016
9 StarPrey $1.4K 90%Positive (21) Nov 23, 2020
10 The Lurking Fear (0)

Get real-time dashboards, historical trends, and AI-powered analysis

Explore on PlayRev(opens in new tab)

Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.